BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
Discoveries/ADAPTIVE IMMUNE SYSTEM
🔒X-Vault sealed — detailed evidence data pending ledger sync. Cryptographic proof of discovery is intact.
✓ X-VAULT VERIFIEDEXPLORATORYNOVELTY: MODERATE

ADAPTIVE IMMUNE SYSTEM

Auto-scan: Adaptive Immune System candidate

discovery score
PubMed Studies
Novelty
Moderate
Signal
Exploratory
Sealed
Mar 8, 2026
BiohacksAI Hypothesis

Adaptive immune system may modulate the Auto-scan: Adaptive Immune System pathway based on its molecular target profile in the BiohacksAI corpus. This compound shows biological activity against validated targets with limited prior literature coverage, suggesting an understudied mechanism-of-action with potential research value.

Computational hypothesis based on target graph analysis. Not a confirmed mechanism. Independent experimental validation required.

Biological Plausibility

The Auto-scan: Adaptive Immune System pathway is a validated biological target area with established relevance in human disease and health research.

Adaptive immune system shows target overlap with compounds previously characterized in this pathway within the BiohacksAI corpus of 31,590 graph entities and 1.51M PubMed studies.

Novelty Indicators
Literature coverage
Pending ledger sync
Low coverage = higher novelty potential
Discovery score
Pending
target_count × pathway_diversity / log(studies + 2)
Mechanism area
Auto-scan: Adaptive Immune System
Primary biological pathway
Novelty rating
Moderate
Derived from score + literature coverage
Research Context
Literature coverage
Detailed data pending ledger sync
X-Vault timestamp
Sealed Mar 8, 2026 — cryptographic proof of discovery date and corpus version
Corpus scope
BiohacksAI corpus only — not a comprehensive literature or patent database search
Mechanism area
Auto-scan: Adaptive Immune System — computationally derived, requires experimental confirmation

This section reflects computational signal strength only. All findings require independent expert validation before any research or commercial use.

Suggested Validation Steps
1Cytokine panel (IL-6, TNF-α, IL-1β)
2NF-κB reporter assay
3Macrophage polarization assay
4T-cell proliferation assay

Validation roadmap is algorithmically derived from pathway context. Full experimental protocol available in Priority Signal discovery reports.

Discovery Lineage
Generated byBiohacksAI Discovery Engine
Engine versionDISCOVERY_v1.1
Corpus versioncurrent
Graph entities31,590 compounds analyzed
PubMed coverage1.51M studies
Discovery dateMarch 8, 2026 at 03:43 PM UTC
X-Vault Evidence SealXVAULT_v1
Discovery IDDISC-pnu74654-20260308-8f2f2a56
Event Hashcbc7343a4ded8373…e5c68ef2
Chain Hash5c2d4974d5cde360…9b4e1c29
Vault Index#15
Sealed At2026-03-08T15:43:17.122Z

Demo report — computational hypothesis only. Not validated. For X-Vault verification testing.

Full Discovery ReportLOCKED
🔒
Mechanism hypothesis (expanded)
Detailed molecular mechanism with target confidence scores and binding context
🔒
Complete target mapping
All validated molecular targets with affinity data and evidence levels
🔒
Biological pathway network
Full pathway coverage map with crosstalk and downstream effects
🔒
Graph position + related compounds
Structural neighbors in the BiohacksAI compound graph — potential analogs
🔒
Supporting PMIDs
Curated PubMed references with relevance ranking
🔒
X-Vault sealed PDF
Cryptographically verified 20-30 page discovery report

Interested in this discovery? Contact us for access and licensing details.

Contact us about this discovery →

All discoveries are computational hypothesis candidates — not confirmed mechanisms. Independent experimental validation is required before any research or commercial use. Organiq Sweden AB · BiohacksAI β